Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | BRS3 | P32247 | 6/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | BAD | Q92934 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | HNF4A | P41235 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14931575 | 0.72 | PPARG (0.45) | — | |
| SCHEMBL2276901 | 0.70 | P2RY14 (0.42) | GAAHSD11B1KDM4EALDH1A1 | |
| SCHEMBL3659233 | 0.69 | NPC1 (0.41) | NPC1GAARAB9AKMT2ABRS3 | |
| SCHEMBL372 | 0.68 | KMT2A (0.60) | NPC1GAARAB9AKMT2ABRS3 | |
| SCHEMBL31402608 | 0.68 | KMT2A (0.60) | NPC1GAARAB9AKMT2ABRS3 | |
| SCHEMBL11142513 | 0.67 | POLB (0.54) | NPC1GAARAB9AKMT2ABRS3 | |
| Hydrochloric Acid SCHEMBL7610390 | 0.67 | KMT2A (0.59) | NPC1GAARAB9AKMT2ABRS3 | |
| SCHEMBL1854636 | 0.67 | NPC1 (0.46) | NPC1GAARAB9AKMT2ABRS3 | |
| SCHEMBL15664279 | 0.66 | POLB (0.49) | NPC1GAARAB9AKMT2ABRS3 | |
| SCHEMBL17965677 | 0.66 | TSHR (0.52) | NPC1GAARAB9AKMT2ABRS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2607356-A1 | Triazole-substituted arylamide derivatives and their use as P2x3 and /or P2x2/3 purinergic receptor antagonists | F. Hoffmann-La Roche AG (CH) | 2013-06-26 | — | — | EP | disclosed |